Your browser doesn't support javascript.
loading
A Pilot Trial for Prevention of Hepatitis C Virus Transmission From Donor to Organ Transplant Recipient With Short-Course Glecaprevir/Pibrentasvir.
Ramirez-Sanchez, Claudia; Kozuch, Jade; Shah, Mita M; Berumen, Jennifer; Mekeel, Kristin; Schnickel, Gabriel; Taremi, Mahnaz; Golts, Eugene; Afshar, Kamyar; Adler, Eric; Pretorius, Victor; Aslam, Saima.
Afiliación
  • Ramirez-Sanchez C; Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, California, USA.
  • Kozuch J; Department of Pharmacy, University of California San Diego, La Jolla, California, USA.
  • Shah MM; Division of Nephrology, University of California San Diego, La Jolla, California, USA.
  • Berumen J; Division of Transplant and Hepatobiliary Surgery, University of California San Diego, La Jolla, California, USA.
  • Mekeel K; Division of Transplant and Hepatobiliary Surgery, University of California San Diego, La Jolla, California, USA.
  • Schnickel G; Division of Transplant and Hepatobiliary Surgery, University of California San Diego, La Jolla, California, USA.
  • Taremi M; Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, California, USA.
  • Golts E; Division of Cardiothoracic Surgery, University of California San Diego, La Jolla, California, USA.
  • Afshar K; Division of Pulmonary and Critical Care, University of California San Diego, La Jolla, California, USA.
  • Adler E; Division of Cardiology, University of California San Diego, La Jolla, California, USA.
  • Pretorius V; Division of Cardiothoracic Surgery, University of California San Diego, La Jolla, California, USA.
  • Aslam S; Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, California, USA.
Open Forum Infect Dis ; 9(11): ofac550, 2022 Nov.
Article en En | MEDLINE | ID: mdl-36420058
A 7-day course of glecaprevir/pibrentasvir started in the preoperative period prevented transmission of hepatitis C virus (HCV) from viremic donors to 10 HCV-negative recipients (2 heart, 1 lung, 6 kidney, 1 heart/kidney) with 100% sustained virological response at 12 weeks.
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Open Forum Infect Dis Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Open Forum Infect Dis Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos